Urge your members of Congress to support continued medical research funding
Donald Trump released a fiscal year 2020 budget request that proposes a 12 percent
cut to the U.S. Department of Health and Human Services (HHS). This includes a $4.716
billion (12.1%) cut to the National Institutes of Health (NIH), the nation’s
largest funder of biomedical research, and a $750 million cut in funding to the
Centers for Disease Control and Prevention (CDC).
ASH is pleased to announce that Carlos Murga-Zamalloa, MD, of the University of Michigan Health System has been selected to participate in the American Society of Hematology-Harold Amos Medical Faculty Development Program.
Roy L. Silverstein, MD, a highly regarded expert in platelet and vascular cell biology as well as clinical non-malignant hematology and thrombosis, will serve as president of ASH for a year-long term through December 2019.
Today, the American Society of Hematology submitted feedback on draft recommendations for reforming Maintenance of Certification (MOC) to a commission appointed by the American Board of Medical Specialties (ABMS) and other entities.
Older adults with cancer are more likely to have had a heart attack or stroke in the months prior to their cancer diagnosis compared with similar adults who do not have cancer during the same period, according to a report published online today in Blood.
The editors of Blood, the most-cited journal in hematology, have selected the top manuscripts of 2018.
In a first-in-human clinical trial reported today in Blood, the investigational drug sutimlimab appeared to be effective in treating cold agglutinin disease, a rare chronic blood disorder for which there are currently no approved treatments.
Today, Congress passed the bi-partisan Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2018.
Three studies being presented today during the 60th ASH Annual Meeting and Exposition in San Diego offer more targeted solutions for managing CLL and multiple myeloma.
Four late-breaking studies being presented today during the 60th ASH Annual Meeting and Exposition in San Diego offer groundbreaking solutions to challenges in diagnosing and managing bleeding and clotting and genetic blood disorders.
Urge your members of Congress to support continued medical research funding.
AMERICAN SOCIETY OF HEMATOLOGY
2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545
by American Society of Hematology